Quick Overview

A combination of B1 inhomogeneity, poor slice profile, and insufficient spoiler gradients between the refocusing pulse and the readout interval of a spin echo sequence results in a FID signal being detected along with the echo.
Since the FID is not phase encoded (normally the phase encoding occurs before the refocusing pulse), it is not dispersed along the phase encoding axis, but appears as a line across the center of the image.

If the problem persists, it must be addressed by a service representative.

Resovist® is an organ-specific MRI contrast agent, used for the detection and characterization of especially small focal liver lesions.
Resovist® consists of superparamagnetic iron oxide (SPIO) nanoparticles coated with carboxydextran, which are accumulated by phagocytosis in cells of the reticuloendothelial system (RES) of the liver. The uptake of Resovist® Injection in the reticuloendothelial cells results in a decrease of the signal intensity of normal liver parenchyma on both T2- and T1 weighted images.
Most malignant liver tumors do not contain RES cells and therefore do not uptake the iron particles. The resulting imaging effect is an improved contrast between the tumor (bright) and the surrounding tissue (dark).
Resovist® can be injected as an intravenous bolus, which allows immediate imaging of the liver and reduces the overall examination time. A dynamic imaging strategy after bolus injection supports to characterize lesions. In comprehensive clinical trials, it demonstrated an excellent safety profile.
In 2001, Resovist® was approved for the European market.

See also Superparamagnetic Iron Oxide.

Resovist® competed with Primovist™, the other liver imaging agent of Bayer Schering Pharma AG. Due to this reason, the production of Resovist® has been abandoned in 2009.

The phased array coils operate typically as receive only coils. In that case, the in the MRI device implemented body coil act as the transmitter and sends the radio frequency energy to generate the excitation pulses. State-of-the-art array coil systems include the use of 4 (up to 32) coils with separate receivers. This method is often referred to as a phased array system, although the signals are not added such that the signal phase information is included. The use of phased array coils allows the decreasing of the number of signal averages, which shortens the scan time by high SNR and resolution.
High-sensitivity RF surface coils and digital processing algorithms have been developed that speed up image acquisition and reconstruction during the MRI scan.
Fast parallel imaging techniques, for example sensitivity encoding (SENSE), 'Partially Parallel Imaging with Localized Sensitivity' (PILS), Simultaneous Acquisition of Spatial Harmonics (SMASH) or Array Spatial Sensitivity Encoding Technique (ASSET) use phased array multichannel coils to further improve spatial and temporal resolution. The sensitivity profile of a phased array coil element is measured by a separate low resolution 3D acquisition over the entire field of view in the case of a SENSE acquisition. For an mSENSE measurement, a self-calibration acquires some of the missing lines in the center of the k-space.
Also called linear array coil or synergy surface coil.

See also the related poll result: '3rd party coils are better than the original manufacturer coils'